Ticker: COCH

Envoy Medical, Inc. (NASDAQ: COCH) has recently released its quarterly report for the period ending June 30, 2025. The company is focused on innovative medical technologies, particularly in the hearing loss sector and is currently developing its flagship product, the Acclaim® cochlear implant. Ke...

Envoy Medical, Inc. (NASDAQ: COCH) is navigating a challenging landscape in the medical technology sector, specifically within the hearing loss domain. For the three months ended March 31, 2025, the company's performance reflects mixed results: Net revenues Cost of Goods Sold (COGS) increased by...